CRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmacology

• Publication date

  2010-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000313836PMID 20559016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.

  2010cited by this paper
• Increased expression of CRTH2 on eosinophils in allergic skin diseases

  2010cited by this paper
• Prostanoid receptor antagonists: development strategies and therapeutic applications

  2009cited by this paper
• Genetic variation in CRTh2 influences development of allergic phenotypes

  2009cited by this paper
• Precarious Balance: Th17 Cells in Host Defense

  2009cited by this paper
• Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.

  2009cited by this paper
• Novel Function of CRTH2 in Preventing Apoptosis of Human Th2 Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway

  2009cited by this paper
• Regulatory T cells and asthma

  2009cited by this paper
• The mechanism and mitigation of niacin-induced flushing

  2009cited by this paper
• Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes.

  2009cited by this paper
• A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep

  2009cited by this paper
• The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains Gαi and Downstream Signaling Cascade Activation*

  2009cited by this paper
• Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls

  2009cited by this paper
• Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.

  2009cited by this paper
• 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.

  2009cited by this paper
• Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms.

  2009cited by this paper
• Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2).

  2009cited by this paper
• Discovery and optimization of CRTH2 and DP dual antagonists.

  2009cited by this paper
• Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa.

  2009cited by this paper
• A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils

  2008cited by this paper
• Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo

  2008cited by this paper
• Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma.

  2008cited by this paper
• Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours.

  2008cited by this paper
• Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2

  2008cited by this paper
• CRTH2‐dependent, STAT6‐independent induction of cedar pollen dermatitis

  2008cited by this paper
• Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors1

  2008cited by this paper
• CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation.

  2008cited by this paper
• Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.

  2008cited by this paper
• Prostaglandin D2 Inhibits the Production of IFN-γ by Invariant NK T Cells: Consequences in the Control of B16 Melanoma1

  2008cited by this paper
• Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation1

  2008cited by this paper
• Targeting eosinophils in asthma.

  2008cited by this paper
• The epidemiology of glucocorticoid-associated adverse events

  2008cited by this paper
• Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2

  2008cited by this paper
• Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.

  2008cited by this paper
• GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells.

  2007cited by this paper
• Eosinophilic disorders.

  2007cited by this paper
• Prostaglandin D2 Suppresses Human NK Cell Function via Signaling through D Prostanoid Receptor1

  2007cited by this paper
• Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2).

  2007cited by this paper
• A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst

  2007cited by this paper
• PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors.

  2007cited by this paper
• 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.

  2007cited by this paper
• Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.

  2007cited by this paper
• Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells

  2007cited by this paper
• Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524).

  2007cited by this paper
• CRTH2 Plays an Essential Role in the Pathophysiology of Cry j 1-Induced Pollinosis in Mice1

  2007cited by this paper
• A paracrine role for chemoattractant receptor‐homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes

  2007cited by this paper
• The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers

  2007cited by this paper
• Association of PTGDR gene polymorphisms with asthma in two Caucasian populations

  2007cited by this paper
• Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation

  2007cited by this paper
• The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking1

  2007cited by this paper
• Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.

  2007cited by this paper
• Discovery of potent CRTh2 (DP2) receptor antagonists.

  2006cited by this paper
• Molecules involved in the regulation of eosinophil apoptosis.

  2006cited by this paper
• Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity.

  2006cited by this paper
• Cutting Edge: Prostaglandin D2 Enhances Leukotriene C4 Synthesis by Eosinophils during Allergic Inflammation: Synergistic In Vivo Role of Endogenous Eotaxin1

  2006cited by this paper
• Hierarchy of eosinophil chemoattractants: role of p38 mitogen‐activated protein kinase

  2006cited by this paper
• Prostaglandin D2-Mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination in twitcher

  2006cited by this paper
• On the Mechanism of Interaction of Potent Surmountable and Insurmountable Antagonists with the Prostaglandin D2 Receptor CRTH2

  2006cited by this paper
• 9alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2.

  2006cited by this paper
• Structural and Functional Characterization of HQL-79, an Orally Selective Inhibitor of Human Hematopoietic Prostaglandin D Synthase*

  2006cited by this paper
• 9α,11β‐PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2

  2006cited by this paper
• Systemic side effects of inhaled corticosteroids in patients with asthma.

  2006cited by this paper
• Inhibitory Effect of the 4-Aminotetrahydroquinoline Derivatives, Selective Chemoattractant Receptor-Homologous Molecule Expressed on T Helper 2 Cell Antagonists, on Eosinophil Migration Induced by Prostaglandin D2

  2005cited by this paper
• Physiological Levels of 15-Deoxy-Δ12,14-Prostaglandin J2 Prime Eotaxin-Induced Chemotaxis on Human Eosinophils through Peroxisome Proliferator-Activated Receptor-γ Ligation1

  2005cited by this paper
• Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells

  2005cited by this paper
• Effects of Prostaglandin D2, 15-Deoxy-Δ12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats

  2005cited by this paper
• 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils.

  2005cited by this paper
• Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor

  2005cited by this paper
• Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist.

  2005cited by this paper
• Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead.

  2005cited by this paper
• Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils

  2005cited by this paper
• Eosinophilic esophagitis: escalating epidemiology?

  2005cited by this paper
• Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation.

  2005cited by this paper
• Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.

  2005cited by this paper
• Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2

  2005cited by this paper
• Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.

  2005cited by this paper
• Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1

  2005cited by this paper
• Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).

  2005cited by this paper
• Prostaglandin D2 mediates neuronal protection via the DP1 receptor

  2005cited by this paper
• Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor‐homologous molecule expressed on Th2 cells/DP2

  2004cited by this paper
• 11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils*

  2004cited by this paper
• Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa.

  2004cited by this paper
• Effects of prostaglandin D2 on helper T cell functions.

  2004cited by this paper
• Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?

  2004cited by this paper
• Adverse effects of short‐acting beta‐agonists: Potential impact when anti‐inflammatory therapy is inadequate

  2004cited by this paper
• Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils

  2004cited by this paper
• Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa

  2004cited by this paper
• Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis.

  2004cited by this paper
• A Critical Role for Eosinophils in Allergic Airways Remodeling

  2004cited by this paper
• Prostaglandin D2 Affects the Maturation of Human Monocyte-Derived Dendritic Cells: Consequence on the Polarization of Naive Th Cells1

  2003cited by this paper
• An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro

  2003cited by this paper
• Δ12-Prostaglandin J2, a Plasma Metabolite of Prostaglandin D2, Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis1

  2003cited by this paper
• Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 1

  2003cited by this paper
• Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma.

  2003cited by this paper
• Novel prostaglandin D(2)-derived activators of peroxisome proliferator-activated receptor-gamma are formed in macrophage cell cultures.

  2003cited by this paper
• Cytokines and chemoattractants in allergic inflammation.

  2002cited by this paper
• Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis.

  2002cited by this paper
• 15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils1

  2002cited by this paper
• Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1

  2002cited by this paper
• Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells

  2002cited by this paper

• Integrating GPCR Regulation and Calcium Dynamics in Airway Smooth Muscle Function: A Comprehensive Review

  2026cites this paper
• Coactosin‐Like Protein Reduces Prostaglandin D2 Production in Alveolar Macrophages and Alleviates Allergic Airway Inflammation

  2025cites this paper
• Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection

  2024cites this paper
• Advances in PGD2/PTGDR2 signaling pathway in tumors: A review

  2024cites this paper
• Serum metabolomics analysis reveals potential biomarkers of penicillins-induced fatal anaphylactic shock in rats

  2024cites this paper
• Tropical urban environments reveal a strong association of CD45RB lo TH2A subset to allergic rhinitis

  2023cites this paper
• Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma

  2023cites this paper
• Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT‐774312

  2023cites this paper
• Human Lung Mast Cells: Therapeutic Implications in Asthma

  2022cites this paper
• Eicosanoids in inflammation in the blood and the vessel

  2022cites this paper
• The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant.

  2021cites this paper
• Identification of Potential inhibitors for Hematopoietic Prostaglandin D2 Synthase: Computational Modeling and Molecular Dynamics Simulations

  2021cites this paper
• Innate lymphoid cells: The missing part of a puzzle in food allergy

  2020cites this paper
• Recent advances in potential targets for eosinophilic esophagitis treatments

  2020cites this paper
• Assessment of T-cell polarization on the basis of surface marker expression: diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome.

  2020cites this paper
• DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment

  2019cites this paper
• Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation.

  2019cites this paper
• Same Target, Different Therapeutic Outcome: The Case of CAY10471 and Fevipiprant on CRTh2 Receptor in Treatment of Allergic Rhinitis and Asthma.

  2019cites this paper
• Crth2 receptor signaling down‐regulates lipopolysaccharide‐induced NF‐αB activation in murine macrophages via changes in intracellular calcium

  2019cites this paper
• Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation

  2019cites this paper
• Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study

  2019cites this paper
• Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives

  2018cites this paper
• The overlap syndrome of urticaria and gastroesophageal reflux disease

  2018cites this paper
• Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition.

  2018cites this paper
• Human mast cells and basophils—How are they similar how are they different?

  2018cites this paper
• Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma

  2018influential citation
• Prostaglandins in the pathogenesis of kidney diseases

  2018cites this paper
• Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists in asthma: a systematic review and meta-analysis protocol

  2018cites this paper
• Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.

  2018cites this paper
• Pathological and therapeutic roles of innate lymphoid cells in diverse diseases

  2017cites this paper
• Review of various molecular targets on mast cells and its relation to obesity: A future perspective.

  2017cites this paper
• Looking forward to new targeted treatments for chronic spontaneous urticaria

  2017cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction

  2017cites this paper
• Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets

  2017cites this paper
• The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh2 antagonists.

  2017cites this paper
• Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives

  2017cites this paper
• Systemic Therapy of Atopic Dermatitis: When, How, for How Long?

  2017cites this paper
• Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy

  2017cites this paper
• Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals

  2016cites this paper
• Automated Affinity Capture and On-Tip Digestion to Accurately Quantitate in Vivo Deamidation of Therapeutic Antibodies.

  2016cites this paper
• Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma

  2016cites this paper
• Investigational prostaglandin D2 receptor antagonists for airway inflammation

  2016cites this paper
• Lipid mediators as regulators of human ILC2 function in allergic diseases.

  2016cites this paper
• Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.

  2016cites this paper
• Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma

  2016cites this paper
• Biological Modulators in Eosinophilic Diseases

  2016cites this paper
• Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung

  2016cites this paper
• Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease.

  2016cites this paper
• 50. Eosinophilic Esophagitis

  2015cites this paper
• Exploring the expression and function of CRTh2 in asthma

  2015cites this paper
• Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma.

  2015cites this paper
• Phosphoinositide‐dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils

  2015cites this paper
• Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties.

  2014cites this paper
• Eosinophils as a pharmacological target for the treatment of allergic diseases.

  2014cites this paper
• Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.

  2014cites this paper
• 15-deoxy-Δ12,14-PGJ2 promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis

  2014cites this paper
• A G protein–coupled receptor and the intracellular synthase of its agonist functionally cooperate

  2014cites this paper
• Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP.

  2014cites this paper
• Molecular targets on mast cells and basophils for novel therapies.

  2014cites this paper
• Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers.

  2014cites this paper
• Opposing Roles of Prostaglandin D2 Receptors in Ulcerative Colitis

  2014cites this paper
• Isoquinoline derivatives as potent, selective, and orally active CRTH2 antagonists.

  2014cites this paper
• Role of prostaglandin D2 and CRTH2 blockade in early‐ and late‐phase nasal responses

  2014cites this paper
• Novel therapies targeting eosinophilic inflammation in asthma

  2014cites this paper
• 21 – Pathophysiology of Allergic Inflammation

  2014cites this paper
• This information is current as Receptors in Ulcerative Colitis 2 Opposing Roles of Prostaglandin D

  2014cites this paper
• Eosinophil Cell-Cell Communication

  2013cites this paper
• Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR.

  2013cites this paper
• Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells

  2013cites this paper
• Targeting eosinophils in allergy, inflammation and beyond

  2013cites this paper
• New Therapies in Asthma

  2013cites this paper
• Hypereosinophilia-associated Diseases and the Therapeutic Agents in Development

  2013cites this paper
• Role of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents.

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators

  2013cites this paper
• Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma

  2013cites this paper
• Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.

  2013cites this paper
• Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases.

  2013cites this paper
• Disposition and Metabolism of Setipiprant, a Selective Oral CRTH2 Antagonist, in Humans

  2013cites this paper
• Novel targeted therapies for eosinophilic disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

  2013cites this paper
• Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders

  2013cites this paper
• Eosinophil as a target for pathophysiological factors and pharmacological compounds

  2013cites this paper
• Prostanoids receptors signaling in different diseases/cancers progression

  2013cites this paper
• Straightforward protocol for the efficient synthesis of varied N(1)-acylated (aza)indole 2-/3-alkanoic acids and esters: optimization and scale-up.

  2012cites this paper
• D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.

  2012cites this paper
• Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype.

  2012cites this paper
• Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A2α for the Treatment of Asthma

  2012cites this paper
• Clinical reviews in allergy and immunology

  2012cites this paper
• Novel targeted therapies for eosinophilic disorders.

  2012cites this paper
• Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia.

  2012cites this paper
• CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils.

  2012cites this paper
• Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism.

  2012cites this paper
• Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine.

  2012cites this paper
• Recent research and developmental strategy of anti-asthma drugs.

  2012cites this paper
• Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists.

  2012cites this paper
• Pathophysiology of allergic inflammation

  2011cites this paper
• Benzodiazepinone Derivatives as CRTH2 Antagonists.

  2011cites this paper
• Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.

  2011cites this paper
• Basophils: emerging roles in the pathogenesis of allergic disease

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper